Natural Relief 1222
Bryonia 6x, Rhus Toxicodendron 6x
Renu Laboratories, Inc.
Human Otc Drug
NDC 76348-480Natural Relief 1222 also known as Bryonia 6x, Rhus Toxicodendron 6x is a human otc drug labeled by 'Renu Laboratories, Inc.'. National Drug Code (NDC) number for Natural Relief 1222 is 76348-480. This drug is available in dosage form of Lotion. The names of the active, medicinal ingredients in Natural Relief 1222 drug includes Bryonia Alba Root - 2.24 g/224g Toxicodendron Pubescens Leaf - 2.24 g/224g . The currest status of Natural Relief 1222 drug is Active.
Drug Information:
| Drug NDC: | 76348-480 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Natural Relief 1222 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Bryonia 6x, Rhus Toxicodendron 6x |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Renu Laboratories, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Lotion |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | BRYONIA ALBA ROOT - 2.24 g/224g
TOXICODENDRON PUBESCENS LEAF - 2.24 g/224g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 20 Feb, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 23 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | RENU LABORATORIES, INC.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | T7J046YI2B
6IO182RP7A
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 76348-480-32 | 896 g in 1 BOTTLE, PUMP (76348-480-32) | 20 Feb, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Muscle aches and stiffness joint pain and muscle stiffness
Product Elements:
Natural relief 1222 bryonia 6x, rhus toxicodendron 6x stearic acid phenoxyethanol garlic toxicodendron pubescens leaf toxicodendron pubescens leaf propylene glycol myristyl myristate bryonia alba root bryonia alba root squalane white wax water trolamine .alpha.-tocopherol hydrolyzed bovine elastin (base; 1000 mw) marine collagen, soluble menthol almond oil soybean oil aloe vera leaf benzoic acid dehydroacetic acid
Indications and Usage:
Temporry relief of minor pain and stiffness of muscles and joints.
Warnings:
For external use only avoid contact with eyes and open wounds. stop use and ask a doctor if condition persists for more than 3 days or worsens. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away. do not use this product if you are hypersensitive to any of the ingredients. stop use and ask a doctor if condition persists for more than 3 days or worsens. keep out of reach of children.
Dosage and Administration:
Directions apply a small amount of natural relief 1222 to affected areas and massage into skin. use first thing in the morning, before bed, and whenever aches and stiffness flare up.
Stop Use:
Stop use and ask a doctor if condition persists for more than 3 days or worsens.
Package Label Principal Display Panel:
Natural relief 1222 label natural relief 1222 label for 32 oz. 32 oz. nr1222